april
coronaviru
diseas
caus
viru
affect
american
claim
live
month
number
death
project
reach
nearli
current
level
social
distanc
prevent
measur
healthcar
worker
place
live
risk
face
enorm
physic
emot
stress
shortag
test
mask
person
protect
equip
ppe
ventil
threaten
make
predica
wors
unfortun
alreadi
midst
anoth
devast
problem
shortag
medic
critic
manag
medic
shortag
anticip
worsen
time
affect
patient
directli
also
pose
threat
health
safeti
patient
diseas
shortag
includ
medic
tout
promis
therapi
chloroquin
hydroxychloroquin
fact
due
offlabel
prescript
hoard
hydroxychloroquin
difficult
obtain
patient
without
need
drug
manag
rheumatoid
arthriti
autoimmun
disord
even
worrisom
shortag
sed
like
midazolam
propofol
need
patient
intub
place
mechan
ventil
impact
patient
serious
ill
patient
well
patient
respiratori
failur
due
caus
need
critic
care
shortag
exemplifi
sed
may
appli
host
drug
includ
antibiot
vasopressor
unfortun
get
wors
activ
pharmaceut
ingredi
api
mani
commonli
use
medic
come
china
mani
gener
manufactur
import
countri
includ
india
shortag
numer
medic
unrel
sinc
pandem
limit
manufactur
export
worldwid
situat
bound
get
wors
recommend
boost
drug
suppli
exceed
capac
term
vital
medic
suppli
usual
suppli
chain
mechan
administr
process
inadequ
crisi
need
act
urgenc
step
nation
must
take
first
food
drug
administr
fda
must
revamp
regulatori
procedur
dramat
acceler
process
ensur
import
medic
avail
public
mani
drug
shortag
go
gener
drug
due
variou
barrier
gener
drug
one
two
fda
approv
version
avail
sale
unit
state
contrast
countri
europ
india
brand
name
drug
may
multipl
gener
version
made
differ
manufactur
multipl
manufactur
act
protect
shortag
countri
also
lower
cost
recommend
fda
institut
turnaround
approv
import
gener
drug
short
suppli
establish
manufactur
countri
altern
fda
also
grant
immedi
reciproc
approv
select
gener
drug
manufactur
countri
access
drug
must
consid
far
wors
public
agenc
charg
protect
safeti
concern
aris
use
gener
drug
made
establish
manufactur
hitherto
author
sell
unit
state
april
medic
shortag
page
second
feder
govern
must
work
major
brand
name
gener
pharmaceut
compani
boost
mass
manufactur
approv
drug
short
suppli
gener
motor
repurpos
factori
make
ventil
big
pharmaceut
compani
request
divert
factori
manufactur
gener
drug
face
shortag
compani
infrastructur
will
voluntarili
nation
interest
administr
must
invok
defens
product
act
compel
meet
need
countri
third
need
encourag
fund
nonprofit
gener
drug
manufactur
unit
state
civica
rx
instanc
found
goal
overcom
drug
shortag
manufactur
suppli
reduc
cost
concept
need
expand
although
take
time
set
govern
manufactur
essenti
drug
someth
consid
longterm
gener
drug
small
profit
margin
unattract
forprofit
compani
despit
critic
need
fourth
api
activ
chemic
substanc
prescript
drug
current
manufactur
china
recommend
control
cost
even
increas
amount
avail
drug
must
take
step
keep
cost
wit
hand
sanit
mask
suppli
limit
price
go
dramat
case
prescript
drug
alreadi
major
problem
control
price
even
prior
pandem
fail
take
strict
measur
access
life
save
medic
limit
cost
disproportion
affect
uninsur
peopl
elderlyth
one
vulner
make
treatment
vaccin
becom
avail
access
afford
therefor
critic
must
pursu
contract
manufactur
especi
new
antivir
drug
vaccin
netflix
option
receiv
fix
reimburs
unlimit
suppli
netflix
model
success
provid
hepat
c
drug
state
louisiana
also
recommend
law
enact
immedi
author
medicar
negoti
price
relat
drug
alway
overwhelm
public
support
medicar
negoti
someth
must
ever
help
keep
price
lower
last
resort
feder
govern
will
issu
compulsori
licens
negoti
compani
fail
reach
agreement
reason
price
allow
govern
licens
use
patent
invent
third
parti
govern
agenc
without
consent
patenthold
negoti
patent
owner
unsuccess
anoth
major
factor
increas
price
relat
drug
unit
state
pharmaci
benefit
manag
pbm
normal
act
middlemen
drug
manufactur
pharmaci
insur
pbm
suppos
deliv
valu
insur
insur
public
identifi
best
option
formulari
placement
negoti
lower
price
howev
alway
case
pbm
may
favor
expens
drug
inexpens
altern
best
illustr
insulin
price
steadili
contribut
increas
list
price
even
older
insulin
prepar
result
higher
retail
price
disproportion
affect
uninsur
underinsur
public
prevent
problem
feder
govern
must
prohibit
deduct
rebat
specif
drug
like
mani
atrisk
resourc
crisi
medic
shortag
invis
threaten
abil
overcom
pandem
also
health
patient
diseas
fragil
complex
medic
suppli
chain
creat
overnight
yet
must
overcom
limit
rapidli
decis
must
act
late
